Search
for
Sort by
Research 30 of 1000+
- The Safety of Local Hormonal Treatment for Vulvovaginal Atrophy in Women With Estrogen Receptor-positive Breast Cancer Who Are on Adjuvant Aromatase Inhibitor Therapy: Meta-analysis
- Analysis of quantitative changes in hair growth during treatment with chemotherapy or tamoxifen in patients with breast cancer: a cohort study
- Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries
- Pegylated Liposomal Doxorubicin in the Treatment of Breast Cancer
- Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients
- Breast Cancer: The Psychological Impact of Diagnosis, Treatment, and Remission
- Hormone therapy in the treatment of breast cancer and main outcomes in sexuality
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- Novel electroporation-based treatments for breast cancer
- Chemotherapy-Induced Alopecia in Breast Cancer Patients: Treatment-Specific Incidence and Risk of Persistent Hair Loss
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Hair regrowth in endocrine therapy alopecia with dutasteride treatment in woman with estrogen positive breast cancer
- The evolution of primary multimodality treatment in resectable breast cancer
- Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review
- Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer
- Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors
- Abstract P5-09-21: Selective androgen receptor modulators (SARMs): Enobosarm as targeted therapy for the treatment of androgen receptor-positive breast cancer
- Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
- The Role of Herbal Medicine in Breast Cancer Treatment: Evidence for Therapeutic Effectiveness
- Assessment of hair loss and skin changes during treatment in Asian breast cancer patients: A prospective cohort study
- Platelet-Rich Plasma Treatment for Endocrine-Induced Alopecia and Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors: A Randomized, Controlled, Pilot Study
- Persistent Alopecia in a Breast Cancer Patient Following Taxane Chemotherapy and Adjuvant Endocrine Therapy: Case Report and Review of Post-treatment Hair Loss in Oncology Patients with Breast Cancer
- Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.
- Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis
- A prospective exploration of symptom burden clusters in women with breast cancer during chemotherapy treatment
- Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
- Evaluation of trichodynia (hair pain) during chemotherapy or tamoxifen treatment in breast cancer patients
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- The Potential of Ultrasound Technology and Chemotherapy Carriers in Breast Cancer Treatment
- Anlotinib or Bevacizumab Combined with Taxane/Capecitabine for the Second-Line or Subsequent Treatment of HER-2 Negative Metastatic Breast Cancer: A Retrospective Cohort Study